Stock listing
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
Selected listing: SKBBY · OTC · USD · US
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H (OTC:SKBBY), Health Technology. Latest release Oct 2, 2026: Monthly Return of Equity Issuer…
- Ticker
- OTC:SKBBY
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
The company focuses on biopharmaceutical development and manufacturing. Its operations are aimed at advancing healthcare solutions through innovative biotechnology.
Latest news from Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 2, 2026
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
September 22, 2026
Results from Phase III Study of Trastuzumab Botidotin versus T-DM1 in HER2-Positive Breast Cancer Published in JCO
September 14, 2026
Kelun-Biotech Announces 2026 Interim Results
August 17, 2026
NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
July 30, 2026
All Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H news →
Research Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H company profile
View the public company page for Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H on 6ix.
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H news
Read company news and market updates connected to Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H.
Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H investor events
Find investor webinars, events, and replay context for Sichuan Kelun-biotech Biopharmaceutical Co., Ltd. Class H.